Now showing items 1-1 of 1

    • Santolaya de Pablo, María Elena; O'Ryan Gallardo, Miguel; Valenzuela, María Teresa; Prado Jiménez, Valeria; Vergara, Rodrigo F.; Muñoz, Alma; Toneatto, Daniela; Graña, Gabriela; Wang, Huajun; Dull, Peter M. (Taylor & Francis, 2013)
      We previously demonstrated the immunogenicity and tolerability of the serogroup B meningococcal vaccine, 4CMenB (Bexsero®), in 11-17 y-olds randomized to receive 1, 2, or 3 doses at 1, 2, or 6 mo intervals. participants ...